Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data

[1]  Li Ding,et al.  The Pediatric Cancer Genome Project , 2012, Nature Genetics.

[2]  Jinghui Zhang,et al.  Association of age at diagnosis and genetic mutations in patients with neuroblastoma. , 2012, JAMA.

[3]  Li Ding,et al.  Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.

[4]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[5]  Matthew W. Wilson,et al.  A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses , 2011, Nature.

[6]  Michael C. Rusch,et al.  CREST maps somatic structural variation in cancer genomes with base-pair resolution , 2011, Nature Methods.

[7]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[8]  Kenneth H. Buetow,et al.  Bioinformatics Applications Note Sequence Analysis Bambino: a Variant Detector and Alignment Viewer for Next-generation Sequencing Data in the Sam/bam Format , 2022 .

[9]  T. Fennell,et al.  Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries , 2011, Genome Biology.

[10]  M. Fenech,et al.  A quantitative PCR method for measuring absolute telomere length , 2011, Biological Procedures Online.

[11]  Ronghua Chen,et al.  DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing , 2010, BMC Genomics.

[12]  J. Uhm.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .

[13]  Philip Thomas,et al.  A quantitative real-time PCR method for absolute telomere length. , 2008, BioTechniques.

[14]  T. Giordano,et al.  Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma. , 2008, The Journal of clinical endocrinology and metabolism.

[15]  R. Reddel,et al.  Telomere uncapping and alternative lengthening of telomeres , 2008, Mechanisms of Ageing and Development.

[16]  J. Dome,et al.  Telomere Biology of Pediatric Cancer , 2007, Cancer investigation.

[17]  Dihua Yu,et al.  A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  M. Valentine,et al.  Telomerase expression predicts unfavorable outcome in osteosarcoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  N. Carter,et al.  A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.

[20]  M. Greaves,et al.  Leukemia in twins: lessons in natural history. , 2003, Blood.

[21]  M. Ladanyi,et al.  Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. , 2003, Cancer research.

[22]  J. Royds,et al.  Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme , 2003, The Lancet.

[23]  J. Skurnick,et al.  Telomere Length in the Newborn , 2002, Pediatric Research.

[24]  R. Cawthon.  Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.

[25]  Adrian E. Raftery,et al.  Model-based clustering and data transformations for gene expression data , 2001, Bioinform..

[26]  J. Fajkus,et al.  Telomerase activity and expression and telomere analysis in situ in the course of treatment of childhood leukemias. , 2000, Blood cells, molecules & diseases.

[27]  R. Reddel,et al.  Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. , 1999, Cancer research.

[28]  M. Engelhardt,et al.  Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy , 1998, Leukemia.

[29]  R. Reddel,et al.  The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. , 1997, Human molecular genetics.

[30]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[31]  E. Hiyama,et al.  Length of Telomeric Repeats in Neuroblastoma: Correlation with Prognosis and Other Biological Characteristics , 1992, Japanese journal of cancer research : Gann.